Treatment-related adverse events
| N = 22 . | Grades 3 and 4, N (%) . |
|---|---|
| Fatigue | 2 (9) |
| Respiratory infections | 4 (18) |
| Gastrointestinal bleeding | 1 (5) |
| Increased creatinine | 1 (5) |
| Atrial fibrillation | 4 (18) |
| Congestive heart failure | 3 (14) |
| Lymphopenia | 3 (14) |
| Diarrhea | 2 (9) |
| N = 22 . | Grades 3 and 4, N (%) . |
|---|---|
| Fatigue | 2 (9) |
| Respiratory infections | 4 (18) |
| Gastrointestinal bleeding | 1 (5) |
| Increased creatinine | 1 (5) |
| Atrial fibrillation | 4 (18) |
| Congestive heart failure | 3 (14) |
| Lymphopenia | 3 (14) |
| Diarrhea | 2 (9) |